PUBLISHER: The Business Research Company | PRODUCT CODE: 1942636
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942636
Cryoablation devices are specialized medical tools utilized for cryoablation procedures, which involve using extreme cold to eliminate abnormal tissues such as tumors or malfunctioning heart tissue. These devices are pivotal in modern medicine, offering a minimally invasive method for treating specific medical conditions by freezing targeted tissues under controlled conditions.
There are several types of cryoablation devices, including probes, tissue contact probe ablators, epidermal and subcutaneous cryoablation systems, generators, and associated accessories and consumables. The design and configuration of the cryoablation probe, categorized by probe type, are crucial in enhancing the effectiveness, safety, and precision of cryoablation procedures across various medical disciplines. Cryoablation finds applications in cardiology, oncology, and other medical fields, serving diverse end-users such as hospitals, ambulatory surgical centers, and specialty clinics.
Tariffs are impacting the cryoablation devices market by increasing costs for imported cryoprobes, generators, gas cartridges, and precision-engineered components used in advanced ablation systems. These cost pressures have particularly affected integrated cryoablation systems and disposable consumables, with asia-pacific and europe experiencing higher exposure due to global sourcing dependencies. Increased tariffs have raised capital and procedural costs for hospitals and specialty centers. However, tariffs have also encouraged local manufacturing, component localization, and regional supply chain diversification, supporting long-term market resilience.
The cryoablation devices market research report is one of a series of new reports from The Business Research Company that provides cryoablation devices market statistics, including cryoablation devices industry global market size, regional shares, competitors with a cryoablation devices market share, detailed cryoablation devices market segments, market trends and opportunities, and any further data you may need to thrive in the cryoablation devices industry. This cryoablation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryoablation devices market size has grown rapidly in recent years. It will grow from $0.61 billion in 2025 to $0.67 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rising incidence of cancer and cardiac arrhythmias, increasing adoption of minimally invasive treatment options, growth in interventional oncology procedures, expansion of cardiac electrophysiology services, improved clinical outcomes of cryoablation therapies.
The cryoablation devices market size is expected to see strong growth in the next few years. It will grow to $0.96 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growing demand for organ-sparing cancer treatments, increasing preference for minimally invasive alternatives to surgery, rising adoption of ablation therapies in early-stage disease management, expansion of specialty treatment centers, continuous advancements in ablation probe and system design. Major trends in the forecast period include rising adoption of minimally invasive cryoablation procedures, increasing use of cryoablation in oncology and cardiology, growing preference for image-guided ablation techniques, expansion of outpatient and ambulatory cryoablation treatments, increasing demand for precision-controlled tissue ablation.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the cryoablation devices market in the coming years. Cardiovascular diseases (CVD) include a range of heart and blood vessel disorders, such as coronary artery disease, hypertension, heart failure, arrhythmias, and stroke. The rise in CVD cases is attributed to factors like aging populations, increasing obesity rates, and greater exposure to risk factors like smoking and pollution. Cryoablation devices are essential in cardiology for treating arrhythmias, such as atrial fibrillation, by creating controlled lesions in heart tissue to disrupt abnormal electrical pathways, helping restore normal heart rhythm and enhancing patient quality of life. For example, in February 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, Blackpool recorded 185 deaths from cardiovascular disease in 2023, compared to 178 deaths in 2022. As such, the rising prevalence of cardiovascular diseases is expected to fuel the growth of the cryoablation devices market.
Rising healthcare expenditure is expected to drive the growth of the cryoablation devices market in the coming years. Healthcare expenditure includes total spending on medical services, public health programs, and health-related goods aimed at maintaining or improving population health. The increase in healthcare spending is largely driven by the growing burden of chronic diseases, which require ongoing treatment, long-term medications, and frequent medical care. Higher healthcare expenditure enables hospitals to adopt cryoablation devices by investing in advanced minimally invasive treatment technologies, expanding procedural capacities, and improving patient access to modern therapeutic options. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Consequently, rising healthcare expenditure is supporting the expansion of the cryoablation devices market.
Leading companies in the cryoablation devices market are concentrating on the development of innovative products, such as cryoprobes, to improve the precision and effectiveness of treatments. A cryoprobe is a medical instrument used in cryotherapy, a procedure that applies extreme cold to tissue in order to treat conditions like tumors, lesions, or abnormal growths. For example, in May 2023, Varian, a U.S.-based medical device company and part of Siemens Healthineers, launched the Isolis cryoprobe. The Isolis cryoprobe is a single-use, disposable device designed to enhance precision and efficiency in cryoablation procedures, where tissue is carefully frozen to address conditions like tumors. It provides interventional radiologists with improved control through its sharp tip and optional integration with the Siemens Healthineers myNeedle Laser guidance system for precise probe placement.
Major companies operating in the cryoablation devices market are Medtronic plc, Boston Scientific Corporation, CooperSurgical Inc., MicroPort Scientific Corporation, AtriCure Inc., Vimecon GmbH, Erbe Elektromedizin GmbH, MedGyn Products Inc., HealthTronics Inc., METRUM CRYOFLEX Sp. z o.o., Adagio Medical Inc., Channel Medsystems Inc., CPSI Biotech, CryoTherapeutics GmbH, Endocare Inc., Galil Medical Ltd., Sanarus Technologies Inc., IceCure Medical Ltd., AngioDynamics Inc., CryoConcepts GmbH
North America was the largest region in the cryoablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cryoablation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cryoablation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cryoablation devices market consists of sales general cryoprobes, cryogen delivery systems, cryoablation consoles, imaging guidance systems, and portable cryoablation systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cryoablation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cryoablation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cryoablation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cryoablation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.